ketanserin has been researched along with Bilirubinemia in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe neonatal hyperbilirubinemia has been known to cause the clinical syndrome of kernicterus and a milder one the syndrome of bilirubin-induced neurologic dysfunction (BIND)." | 4.12 | Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin. ( Arauchi, R; Fukushima, M; Hashioka, S; Hayashida, M; Inagaki, M; Miura, S; Miyaoka, T; Oh-Nishi, A; Otsuki, K; Tsuchie, K; Tsumori, T; Wake, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, S | 1 |
| Tsuchie, K | 1 |
| Fukushima, M | 1 |
| Arauchi, R | 1 |
| Tsumori, T | 1 |
| Otsuki, K | 1 |
| Hayashida, M | 1 |
| Hashioka, S | 1 |
| Wake, R | 1 |
| Miyaoka, T | 1 |
| Inagaki, M | 1 |
| Oh-Nishi, A | 1 |
1 other study available for ketanserin and Bilirubinemia
| Article | Year |
|---|---|
Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.
Topics: Animals; Bilirubin; Humans; Hyperbilirubinemia; Kernicterus; Ketanserin; Rats; Rats, Gunn; Rats, Wis | 2022 |